WHO WE ARE

Waverley Pharma was founded in 2014 and became a public company in October 2017. The company trades under the symbol WAVE on the TSX Venture Exchange. Waverley Pharma Inc. is a specialty pharma company that is dedicated to the development and commercialization of safe, effective and affordable therapeutics.

WHAT WE BELIEVE IN

We believe in developing and commercializing safe and effective pharmaceuticals to treat human diseases. In the changing healthcare environment, you can count on Waverley Pharma to remain dedicated to the safety, quality, effectiveness and affordability of the therapeutics.

WHAT WE DO

At Waverley Pharma, we are committed to discovering innovative small molecule drugs to combat diseases. Over the past few years, Waverley Pharma has developed a strong PARP-1 inhibitor program. Understanding the need for effective and selective PARP-1 inhibitors, our ongoing oncology project aims to discover novel, potent, and selective compounds for PARP-1 inhibition. Learn more about how the Waverley Pharma team contributes to making a difference.

PARP-1 Inhibitors

Oncology R&D

Waverley Pharma's R&D project aims to discover novel, potent, and selective PARP-1 inhibitors. We have successfully identified several highly potent and selective PARP-1 lead compounds.

about our compounds

Waverley Pharma acquired C & R Pharmacy, based in West Liberty, Ohio, in 2024. C & R Pharmacy provides all your medical and pharmaceutical needs. Our  dedicated team cares about patients and the quality of pharmaceuticals they use. We seek to provide affordable medications and lower healthcare costs for all customers in the United States of America.

C & R Pharmacy

A Caring and Respectful Pharmacy

Let our pharmacy and medical supply services take care of all your health needs. When you come to C & R Pharmacy, you can be certain you'll only get the best of service.

about c&r pharmacy

Waverley Pharma is open to collaborations and partnerships. Waverley Pharma has developed a strong PARP-1 inhibitor program. Discover the pipeline of novel compounds selective in inhibition of PARP-1 enzyme. Please give us a call or send us an email if you have questions about our ongoing science, future plans or any other aspect of Waverley Pharma.

Connect with the Waverley Pharma team

Collaborate With Us

Waverley Pharma is open to collaborations and partnerships for the commercialization of our pipeline.

connect with our team